HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angela Dispenzieri Selected Research

Bortezomib (Velcade)

4/2024Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
12/2023POEMS syndrome: Update on diagnosis, risk-stratification, and management.
11/2023Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma.
9/2023Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study.
1/2022Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis.
12/2021The Role of Autologous Stem Cell Transplantation in Amyloidosis.
1/2021Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
1/2021Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma.
1/2021POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management.
11/2020Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angela Dispenzieri Research Topics

Disease

176Multiple Myeloma
03/2024 - 11/2002
144Immunoglobulin Light-chain Amyloidosis
04/2024 - 03/2002
139Amyloidosis
03/2024 - 01/2002
32Paraproteinemias (Monoclonal Gammopathy)
01/2022 - 01/2002
27POEMS Syndrome (Syndrome, POEMS)
12/2022 - 04/2003
26Neoplasms (Cancer)
12/2023 - 01/2005
20Plasmacytoma
12/2023 - 06/2004
19Monoclonal Gammopathy of Undetermined Significance
11/2022 - 07/2004
17Amyloid Plaque
12/2023 - 01/2002
16Peripheral Nervous System Diseases (PNS Diseases)
12/2023 - 01/2005
16Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021 - 01/2002
15Cardiomyopathies (Cardiomyopathy)
11/2022 - 01/2002
14Disease Progression
11/2023 - 07/2004
13Polyradiculoneuropathy (Polyradiculoneuritis)
12/2023 - 07/2011
13Proteinuria
01/2022 - 01/2005
12Castleman Disease (Castleman's Disease)
12/2023 - 07/2011
11Heart Failure
02/2024 - 04/2014
10Anemia
12/2023 - 01/2003
10Transthyretin-Related Hereditary Amyloidosis
11/2023 - 07/2014
10Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 02/2005
9Smoldering Multiple Myeloma
01/2021 - 07/2004
7Lymphoma (Lymphomas)
01/2021 - 03/2011
6Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 07/2004
6Thrombocytosis (Thrombocythemia)
01/2022 - 05/2008
6Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2018 - 01/2005
5Pleural Effusion (Pleural Effusions)
12/2023 - 06/2010
5Acute Kidney Injury (Acute Renal Failure)
07/2023 - 01/2005
5Infections
01/2023 - 11/2002
5Polyneuropathies (Polyneuropathy)
01/2021 - 05/2015
5Hypercalcemia (Milk Alkali Syndrome)
01/2020 - 01/2003
5Thrombocytopenia (Thrombopenia)
01/2020 - 04/2006
5Renal Insufficiency (Renal Failure)
12/2019 - 06/2010
5Familial Amyloidosis (Hereditary Amyloidosis)
01/2018 - 07/2014
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 03/2003
4Kidney Diseases (Kidney Disease)
12/2023 - 01/2012
4Pulmonary Hypertension
12/2023 - 01/2015
4Hypoalbuminemia
01/2022 - 01/2005
4Rare Diseases (Rare Disease)
01/2021 - 01/2008
4Trisomy (Trisomies)
12/2020 - 09/2005
4Cardiac Arrhythmias (Arrythmia)
12/2019 - 06/2010
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018 - 09/2006
3Fatigue
12/2023 - 01/2007
3Hemorrhage
07/2023 - 03/2003
3Thrombosis (Thrombus)
01/2023 - 12/2019

Drug/Important Bio-Agent (IBA)

75Amyloid (Amyloid Fibrils)IBA
03/2024 - 03/2003
74Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2002
43Dexamethasone (Maxidex)FDA LinkGeneric
04/2024 - 01/2002
43Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2021 - 07/2005
37Immunoglobulins (Immunoglobulin)IBA
12/2023 - 11/2005
31Bortezomib (Velcade)FDA Link
04/2024 - 07/2005
31Lenalidomide (CC 5013)FDA Link
03/2024 - 10/2006
28Prealbumin (Transthyretin)IBA
03/2024 - 12/2013
28Immunoglobulin M (IgM)IBA
01/2021 - 01/2002
22Thalidomide (Thalomid)FDA Link
12/2023 - 11/2002
17Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2010
17Melphalan (Alkeran)FDA LinkGeneric
01/2023 - 01/2002
16Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2024 - 03/2006
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 05/2008
10Congo RedIBA
12/2023 - 04/2013
10Brain Natriuretic Peptide (Natrecor)FDA Link
01/2019 - 09/2004
9Troponin T (Troponin T1)IBA
01/2021 - 05/2007
8Immunoglobulin G (IgG)IBA
01/2022 - 06/2010
8Proteasome InhibitorsIBA
01/2022 - 05/2006
8pro-brain natriuretic peptide (1-76)IBA
01/2021 - 10/2010
8CreatinineIBA
12/2020 - 01/2002
7daratumumabIBA
04/2024 - 11/2017
7ixazomibIBA
01/2023 - 11/2016
6Serum AlbuminIBA
12/2023 - 11/2005
6Immunomodulating AgentsIBA
01/2022 - 10/2009
6pomalidomideIBA
03/2021 - 10/2009
6Immunoglobulin A (IgA)IBA
01/2021 - 06/2010
6Interleukin-6 (Interleukin 6)IBA
12/2020 - 02/2006
6Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2019 - 10/2003
5Blood Proteins (Serum Proteins)IBA
12/2023 - 12/2011
5thiamine triphosphorate (TTP)IBA
11/2023 - 04/2003
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2003
5TroponinIBA
10/2019 - 05/2003
5Peptides (Polypeptides)IBA
02/2017 - 04/2014
4ProteomeIBA
12/2023 - 07/2013
4patisiranIBA
01/2021 - 01/2019
4AlbuminsIBA
12/2020 - 05/2007
4VaccinesIBA
12/2020 - 12/2009
4Radioisotopes (Radionuclides)IBA
01/2020 - 01/2002
4Rituximab (Mabthera)FDA Link
08/2018 - 09/2006
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018 - 03/2007
4Indicators and Reagents (Reagents)IBA
10/2015 - 02/2003
4Alkylating AgentsIBA
05/2012 - 03/2003
3Hemoglobins (Hemoglobin)IBA
01/2022 - 01/2018
3sodium-iodide symporter (sodium iodide symporter)IBA
01/2022 - 10/2017

Therapy/Procedure

162Therapeutics
03/2024 - 01/2002
85Stem Cell Transplantation
11/2023 - 11/2002
28Drug Therapy (Chemotherapy)
01/2023 - 11/2002
17Transplantation
01/2023 - 03/2003
13Hematopoietic Stem Cell Transplantation
03/2021 - 03/2004
12Kidney Transplantation
04/2022 - 07/2005
11Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2015 - 01/2002
9Autologous Transplantation
01/2017 - 12/2009
8Cell Transplantation
12/2022 - 08/2011
5Lasers (Laser)
12/2023 - 12/2010
5Radiotherapy
11/2023 - 07/2005